Q&A

Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.

by Marci A. Landsmann

Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.

by Kate Yandell

People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

by Jon Kelvey

Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.

by Emma Yasinski

Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.

by Ashley P. Taylor

For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.

by Kate Yandell

Healthy Habits

Public awareness of the link between obesity and cancer risk is poor.

by Jane C. Hu

When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.

by Sue Rochman

From the Editor-in-Chief

DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop.

by William G. Nelson, MD, PhD

Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.

by Kate Yandell